Royal DSM N.V. announced that Hans van Suijdam will be appointed as the Director Corporate Operational Audit (COA) and Compliance Officer, effective April 1, 2009.

Van Suijdam is currently the Director Strategic Projects in China. His current assignment in China, including activities related to the strategic partnership of DSM with North China Pharmaceutical Group Corporation will be taken over and continued by Jiang Weiming, President of DSM China.

In his new role as Director Corporate Operational Audit and Compliance Officer, Hans van Suijdam succeeds Roelof Mulder, who passed away in November last year.

Hans van Suijdam will report to F. Sijbesma, Chairman of the DSM Managing Board.

Royal DSM N.V, a life sciences and materials sciences company in the Netherlands, have end markets that include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing.